Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06432 | 32882583 | Biomed Pharmacother | An update on β-sitosterol: A potential herbal nutraceutical for diabetic management. | 2020 | Details |
| A06433 | 32882428 | Clin Gastroenterol Hepatol | Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A06441 | 32880109 | Rev Med Suisse | [NASH: new terminology and what else is new in 2020]. | 2020 | Details |
| A06449 | 32878486 | Expert Rev Gastroenterol Hepatol | Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy? | 2020 | Details |
| A06451 | 32877694 | Pharmacol Res | Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action. | 2020 | Details |
| A06469 | 32868652 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study. | 2021 | Details |
| A06471 | 32867260 | Medicina (Kaunas) | Probiotics: Versatile Bioactive Components in Promoting Human Health. | 2020 | Details |
| A06495 | 32853691 | Diabetes Res Clin Pract | Development and validation of screening scores of non-alcoholic fatty liver disease in middle-aged and elderly Chinese. | 2020 | Details |
| A06496 | 32853678 | J Nutr Biochem | N-3 PUFAs inhibited hepatic ER stress induced by feeding of a high-saturated fat diet accompanied by the expression LOX-1. | 2020 | Details |
| A06521 | 32841652 | J Allergy Clin Immunol | Regulating metabolic inflammation by nutritional modulation. | 2020 | Details |
| A06533 | 32836224 | Dig Dis | Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease. | 2020 | Details |
| A06546 | 32831531 | Med Chem Res | Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity. | 2020 | Details |
| A06547 | 32830817 | J Gastrointestin Liver Dis | Non-alcoholic Steatohepatitis: Comparison of Intestinal Microbiota between Different Metabolic Profiles. A Pilot Study. | 2020 | Details |
| A06563 | 32824349 | Antioxidants (Basel) | Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06572 | 32822391 | PLoS One | Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus. | 2020 | Details |
| A06580 | 32821336 | World J Hepatol | Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study. | 2020 | Details |
| A06587 | 32819262 | Curr Drug Saf | Efficacy and Cardiovascular Safety of DPP-4 Inhibitors. | 2021 | Details |
| A06590 | 32816619 | Gut Microbes | Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease. | 2020 | Details |
| A06593 | 32815873 | J Clin Gastroenterol | Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases. | 2021 | Details |
| A06596 | 32813194 | Hepatol Int | Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study. | 2020 | Details |
| A06598 | 32812930 | Metabol Open | PIN1, a perspective on genetic biomarker for nonalcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A06601 | 32812688 | Pediatr Diabetes | Effects of fatty liver on the size and composition of high-density lipoprotein cholesterol subpopulations in adolescents with type 2 diabetes mellitus. | 2020 | Details |
| A06622 | 32804855 | Eur J Gastroenterol Hepatol | Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. | 2021 | Details |
| A06629 | 32801014 | Clin Gastroenterol Hepatol | Associations Between Reproductive and Hormone-Related Factors and Risk of Nonalcoholic Fatty Liver Disease in a Multiethnic Population. | 2020 | Details |
| A06641 | 32797346 | Dig Dis Sci | Racial and Socioeconomic Disparities in Hospitalization of Pediatrics with Liver Disease from 2005 to 2015. | 2020 | Details |
| A06665 | 32789148 | Clin Nutr Res | Association between Inflammatory Biomarkers and Nutritional Status in Fatty Liver. | 2020 | Details |
| A06667 | 32788075 | Surg Obes Relat Dis | Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy. | 2020 | Details |
| A06674 | 32785059 | Nutrients | Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral. | 2020 | Details |
| A06679 | 32782954 | JGH Open | Effect of telmisartan and vitamin E on liver histopathology with non-alcoholic steatohepatitis: A randomized, open-label, noninferiority trial. | 2020 | Details |
| A06684 | 32781086 | Gastroenterology | Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis. | 2020 | Details |
| A06689 | 32780094 | Inflamm Bowel Dis | Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. | 2021 | Details |
| A06693 | 32777485 | Phytomedicine | Cajanolactone A, a stilbenoid from cajanus cajan, prevents ovariectomy-induced obesity and liver steatosis in mice fed a regular diet. | 2020 | Details |
| A06695 | 32777481 | Biochim Biophys Acta Mol Cell Biol Lipids | Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis. | 2020 | Details |
| A06700 | 32775974 | JHEP Rep | Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease. | 2020 | Details |
| A06707 | 32774711 | Am J Transl Res | Changes and roles of intestinal fungal microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease. | 2020 | Details |
| A06734 | 32765812 | Nutr Res Pract | Folic acid supplementation prevents high fructose-induced non-alcoholic fatty liver disease by activating the AMPK and LKB1 signaling pathways. | 2020 | Details |
| A06744 | 32763196 | Lancet Gastroenterol Hepatol | A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study. | 2020 | Details |
| A06748 | 32760938 | Food Funct | Dietary citrus peel essential oil ameliorates hypercholesterolemia and hepatic steatosis by modulating lipid and cholesterol homeostasis. | 2020 | Details |
| A06757 | 32758151 | BMC Gastroenterol | Evaluation of NAFLD and fibrosis in obese patients - a comparison of histological and clinical scoring systems. | 2020 | Details |
| A06767 | 32754976 | Mol Nutr Food Res | Metabolic Inflammation in Obesity-At the Crossroads between Fatty Acid and Cholesterol Metabolism. | 2020 | Details |
| A06771 | 32752595 | J Prev Med Public Health | Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women. | 2020 | Details |
| A06777 | 32751658 | Cells | The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders. | 2020 | Details |
| A06780 | 32748703 | Exp Lung Res | Quantitative analysis of the global proteome in lung from mice with blast injury. | 2020 | Details |
| A06783 | 32747897 | Rom J Morphol Embryol | MR spectroscopy of the liver - a reliable non-invasive alternative for evaluating non-alcoholic fatty liver disease. | 2020 | Details |
| A06807 | 32738385 | Alcohol | Moderate alcohol consumption is not associated with subclinical cardiovascular damage but with hepatic fibrosis in non-alcoholic fatty liver disease. | 2020 | Details |
| A06817 | 32736293 | Nutr Res | Association between eating speed and newly diagnosed nonalcoholic fatty liver disease among the general population. | 2020 | Details |
| A06829 | 32731709 | Wiad Lek | Features of some anthropometric indices and indices of insulin resistance in patients with non-alcoholic steatohepatitis on the background of obesity and osteoarthritis. | 2020 | Details |
| A06837 | 32729704 | Minerva Med | Ancient wheats: beneficial effects on insulin resistance. | 2020 | Details |
| A06846 | 32725250 | Acta Derm Venereol | Hidradenitis Suppurativa is Associated with Non-alcoholic Fatty Liver Disease: A Cross-sectional Study. | 2020 | Details |
| A06848 | 32724826 | J Diabetes Res | A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease. | 2020 | Details |
| A06872 | 32715667 | J Korean Med Sci | Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea. | 2020 | Details |
| A06882 | 32711187 | Transl Res | The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet. | 2020 | Details |
| A06918 | 32698063 | Int J Biol Macromol | Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota. | 2020 | Details |
| A06953 | 32687983 | Environ Toxicol Pharmacol | Early microcystin-LR exposure-linked inflammasome activation in mice causes development of fatty liver disease and insulin resistance. | 2020 | Details |
| A06958 | 32686578 | Expert Opin Emerg Drugs | Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists. | 2020 | Details |
| A06965 | 32684739 | World J Gastroenterol | Medications in type-2 diabetics and their association with liver fibrosis. | 2020 | Details |
| A06966 | 32684526 | Endocr J | Association between hemoglobin levels and non-alcoholic fatty liver disease in patients with young-onset type 2 diabetes mellitus. | 2020 | Details |
| A06970 | 32683103 | Clin Gastroenterol Hepatol | Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06972 | 32682086 | Ann Hepatol | Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis. | 2020 | Details |
| A06973 | 32682050 | J Hepatol | Extracellular vesicles as biomarkers in liver diseases: A clinician's point of view. | 2020 | Details |
| A06979 | 32677717 | Diabetes Metab Res Rev | NAFLD in type 2 diabetes mellitus: Still many challenging questions. | 2020 | Details |
| A06989 | 32671089 | Front Nutr | A Description of Risk Factors for Non-alcoholic Fatty Liver Disease in the Southern Community Cohort Study: A Nested Case-Control Study. | 2020 | Details |
| A06991 | 32670821 | J Tradit Complement Med | Beneficial effects of Chinese herbs in the treatment of fatty liver diseases. | 2020 | Details |
| A07002 | 32664153 | Medicine (Baltimore) | Correlation between the small dense LDL level and nonalcoholic fatty liver disease: Possibility of a new biomarker. | 2020 | Details |
| A07006 | 32663195 | J Clin Invest | Hemolysis transforms liver macrophages into antiinflammatory erythrophagocytes. | 2020 | Details |
| A07026 | 32654086 | Dig Dis Sci | Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C. | 2020 | Details |
| A07029 | 32652744 | Liver Int | MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study. | 2020 | Details |
| A07035 | 32650090 | Comput Methods Programs Biomed | Computer-aided classification of hepatocellular ballooning in liver biopsies from patients with NASH using persistent homology. | 2020 | Details |
| A07061 | 32637906 | JHEP Rep | The liver matrisome - looking beyond collagens. | 2020 | Details |
| A07072 | 32631678 | Rev Neurol (Paris) | Metabolic alterations in spinal and bulbar muscular atrophy. | 2020 | Details |
| A07073 | 32631515 | Bioorg Med Chem Lett | Development of a new class of liver receptor homolog-1 (LRH-1) agonists by photoredox conjugate addition. | 2020 | Details |
| A07084 | 32629123 | Clin Gastroenterol Hepatol | Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases. | 2020 | Details |
| A07087 | 32627871 | J Gastroenterol Hepatol | Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. | 2020 | Details |
| A07088 | 32627436 | J Korean Med Sci | Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia. | 2020 | Details |
| A07094 | 32625166 | Front Endocrinol (Lausanne) | Serum Ferritin Correlates With Liver Fat in Male Adolescents With Obesity. | 2020 | Details |
| A07099 | 32622843 | Metabolism | Defects in High Density Lipoprotein metabolism and hepatic steatosis in mice with liver-specific ablation of Hepatocyte Nuclear Factor 4A. | 2020 | Details |
| A07100 | 32622362 | J Neuroinflammation | Lipocalin 2 induces neuroinflammation and blood-brain barrier dysfunction through liver-brain axis in murine model of nonalcoholic steatohepatitis. | 2020 | Details |
| A07111 | 32619031 | Diabet Med | Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes. | 2020 | Details |
| A07113 | 32618599 | Am J Surg Pathol | Steatohepatitic Variant of Hepatocellular Carcinoma Is Associated With Both Alcoholic Steatohepatitis and Nonalcoholic Steatohepatitis: A Study of 2 Cohorts With Molecular Insights. | 2020 | Details |
| A07115 | 32617199 | IEEE J Transl Eng Health Med | Ultrasound-Based Attenuation Imaging for the Non-Invasive Quantification of Liver Fat - A Pilot Study on Feasibility and Inter-Observer Variability. | 2020 | Details |
| A07128 | 32610115 | J Hepatol | Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. | 2020 | Details |
| A07135 | 32607732 | Hepatol Int | Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction. | 2020 | Details |
| A07140 | 32605642 | BMC Endocr Disord | Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort study using the health improvement network (THIN). | 2020 | Details |
| A07148 | 32602214 | Hepatol Res | Clinical and anthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan. | 2020 | Details |
| A07175 | 32592657 | Cell Metab | In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. | 2020 | Details |
| A07204 | 32583938 | Phytother Res | Extract of Schisandra chinensis fruit protects against metabolic dysfunction in high-fat diet induced obese mice via FXR activation. | 2020 | Details |
| A07206 | 32583511 | Hepatol Res | Liver disease in pregnancy. | 2020 | Details |
| A07213 | 32579995 | Toxicol Lett | Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease. | 2020 | Details |
| A07216 | 32579269 | J Gastroenterol Hepatol | High risk of colorectal polyps in men with non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
| A07231 | 32573497 | JCI Insight | Leptin decreases de novo lipogenesis in patients with lipodystrophy. | 2020 | Details |
| A07240 | 32571100 | J Endourol | Nonalcoholic Fatty Liver Disease Is an Independent Risk Factor for Nephrolithiasis in Women: Findings from NHANES III. | 2020 | Details |
| A07244 | 32569680 | Metabolism | Metabolic liver disease in diabetes - From mechanisms to clinical trials. | 2020 | Details |
| A07257 | 32564624 | Ann Saudi Med | Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation. | 2020 | Details |
| A07260 | 32562818 | Pharmacol Res | ZLY032, the first-in-class dual FFA1/PPARδ agonist, improves glucolipid metabolism and alleviates hepatic fibrosis. | 2020 | Details |
| A07267 | 32559839 | Biomed Pharmacother | Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine. | 2020 | Details |
| A07276 | 32558189 | Liver Int | The risk of pregnancy-associated hypertension in women with nonalcoholic fatty liver disease. | 2020 | Details |
| A07297 | 32552182 | Expert Opin Investig Drugs | Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH). | 2020 | Details |
| A07306 | 32546444 | Dig Liver Dis | Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators. | 2020 | Details |
| A07309 | 32545403 | Int J Mol Sci | Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07312 | 32544255 | Hepatology | From NAFLD to MAFLD: Implications of a Premature Change in Terminology. | 2021 | Details |